Close Menu

NEW YORK (GenomeWeb) – Curetis today reported a 36 percent year-over year increase in revenues for the first half of 2018, largely due to sales of its diagnostic test cartridge and instruments in Europe, the Middle East, and Asia.

For the six-month period ended June 30, Curetis' revenues rose to €807,000 ($919,553) from €595,000 a year earlier. Contributing to the growth was a 257 percent surge in sales from cartridges and instruments in the EMEA market.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.